While EphA2 is overexpressed in many types of cancer, canonical phosphorylation of EphA2 is often reduced due to insufficient cell-cell contact or due to decreased expression of the ephrin-A1 ligand [4, 52, 63, 68]. This evidence concerns the gene EPHA2 and cancer.